ENFUSE Quarterly Results, Profit & Loss, Balance Sheet (ENFUSE)

ENFUSE quarterly results and annual financials: sales, operating profit, OPM, net profit, EPS, balance sheet, cash flow and ratios like ROCE, with YoY and QoQ growth.

  • ENFUSE Financials
  • ENFUSE Shareholding Pattern
  • ENFUSE Earnings Documents
  • ENFUSE Announcements
  • ENFUSE Corporate Actions
  • ENFUSE Bulk, Block & Insider Deals
  • ENFUSE Delivery Data
  • ENFUSE Earnings Concalls
  • Market Timeline
  • Concall Monitor
  • Company Research
  • Earnings Monitor
  • Upcoming Results
  • Sector Monitor
  • Sector Performance
  • Bulk & Block Deals
  • Delivery Data
  • FII & DII Activity
  • Market Indices
  • Plans & Pricing

Enfuse Solutions Ltd (ENFUSE) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow

Enfuse Solutions Ltd reported sales of ₹27 Cr, operating profit of ₹-2 Cr (OPM -7%) and net profit of ₹-7 Cr for the quarter ended Mar 2026. Figures in ₹ crore, consolidated where available.

ENFUSE quarterly results (₹ Cr)
MetricMar 2025Sep 2025Mar 2026
Sales223127
Expenses173629
Operating Profit5-5-2
OPM25%-14%-7%
Other Income001
Interest212
Depreciation234
Profit before tax2-9-7
Tax51%-2%6%
Net Profit1-9-7
EPS in Rs1.04-9.63-7.79
ENFUSE profit & loss, annual (₹ Cr)
MetricMar 2025Mar 2026TTM
Sales435853.47
Expenses336552.52
Operating Profit11-60.95
OPM25%-11%1.78%
Other Income110.93
Interest233.14
Depreciation475.57
Profit before tax5-15-6.83
Tax35%1%-
Net Profit3-15-7.6
EPS in Rs3.66-17.42-8.59
Dividend Payout0%0%-
ENFUSE balance sheet (₹ Cr)
MetricMar 2025Sep 2025Mar 2026
Equity Capital98.859
Reserves2617.6611
Borrowings2528.5429
Other Liabilities811.16
Total Liabilities6866.1555
Fixed Assets1816.3716
CWIP000
Investments54.635
Other Assets4545.1534
Total Assets6866.1555
ENFUSE cash flows (₹ Cr)
MetricMar 2025Mar 2026
Cash from Operating Activity-46
Cash from Investing Activity-13-4
Cash from Financing Activity141
Net Cash Flow-32
Free Cash Flow-171
CFO/OP-21%-100%
ENFUSE ratios
MetricMar 2025Mar 2026
Debtor Days10738
Cash Conversion Cycle10738
Working Capital Days66-37
ROCE--22%
  • ENFUSE Shareholding Pattern
  • ENFUSE Earnings Concalls
  • ENFUSE Growth Catalysts
  • ENFUSE Corporate Actions
  • ENFUSE Announcements
  • ENFUSE Results & Documents
  • ENFUSE Bulk & Block Deals
  • ENFUSE Delivery Data